Panbela Therapeutics, Inc. (PBLA)
USD 0.35
(10.54%)
USD 0.35
(10.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -25.24 Million | -15.27 Million | -6.7 Million | -3.85 Million | -2.73 Million | -2.38 Million |
| Net Income | -25.26 Million | -34.93 Million | -10.13 Million | -4.76 Million | -6.2 Million | -5.9 Million |
| Depreciation & Amortization | - | - | - | 114 Thousand | 2.06 Million | - |
| Deferred income taxes | - | - | - | -114 Thousand | -2.06 Million | - |
| Stock-based compensation | 823 Thousand | 1.08 Million | 1.28 Million | 1.2 Million | 1.09 Million | 1.27 Million |
| Change in working capital | -647 Thousand | 559 Thousand | 2.14 Million | -188 Thousand | 188 Thousand | 494 Thousand |
| Other non-cash items | -162 Thousand | 18.01 Million | 605 Thousand | -103 Thousand | 2.18 Million | 1.74 Million |
| Investing Cash Flow | 400 Thousand | -656 Thousand | -540 Thousand | - | - | - |
| Investments in PPE | - | -660 Thousand | - | - | - | - |
| Acquisitions | - | 4000.00 | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 400 Thousand | -656 Thousand | -540 Thousand | - | - | - |
| Financing Cash Flow | 26.14 Million | 5.35 Million | 10.09 Million | 10.44 Million | 3.78 Million | 3.64 Million |
| Debt repayment | -1.65 Million | - | - | -860 Thousand | -186 Thousand | -14 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -10 Thousand | - | - | - | - | - |
| Common Stock Issuance | 23.05 Million | 5.34 Million | 9.05 Million | 11.08 Million | 3.16 Million | 2.32 Million |
| Other Financing Activities | 24.54 Million | 5000.00 | 1.04 Million | 223 Thousand | 810 Thousand | 1.32 Million |
| Accounts receivables | -132 Thousand | 212 Thousand | 51 Thousand | -2000.00 | -31 Thousand | 50 Thousand |
| Accounts payables | 7.06 Million | 2.24 Million | 631 Thousand | -747 Thousand | 301 Thousand | 360 Thousand |
| Inventory | - | -212 Thousand | -51 Thousand | 2000.00 | 31 Thousand | - |
| Other working capital | -7.06 Million | -1.69 Million | 1.51 Million | 559 Thousand | -113 Thousand | 134 Thousand |
| Cash at beginning of period | 1.28 Million | 11.86 Million | 9.02 Million | 2.44 Million | 1.4 Million | 152 Thousand |
| Cash at end of period | 2.57 Million | 1.28 Million | 11.86 Million | 9.02 Million | 2.44 Million | 1.4 Million |
| Capital Expenditure | - | -660 Thousand | - | - | - | - |
| Effect of forex changes on cash | - | -4000.00 | -6000.00 | -17 Thousand | -1000.00 | -3000.00 |
| Net cash flow / Change in cash | 1.29 Million | -10.58 Million | 2.84 Million | 6.57 Million | 1.04 Million | 1.25 Million |
| Free Cash Flow | -25.24 Million | -15.93 Million | -6.7 Million | -3.85 Million | -2.73 Million | -2.38 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.14 Million | -7.12 Million | -25.26 Million | -6.47 Million | -7.83 Million | -5.83 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 103 Thousand | 823 Thousand | 124 Thousand | 190 Thousand | 329 Thousand |
| Change in working capital | 6.88 Million | -2.4 Million | -647 Thousand | 3.2 Million | 1.3 Million | -296 Thousand |
| Other non-cash items | 53 Thousand | 34 Thousand | -162 Thousand | 66 Thousand | -335 Thousand | 65 Thousand |
| Investing Cash Flow | - | - | 400 Thousand | -7.96 Million | 400 Thousand | 7.96 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | -400 Thousand | 400 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 400 Thousand | -7.56 Million | - | - |
| Financing Cash Flow | - | 7.08 Million | 26.14 Million | 4.74 Million | -19 Thousand | 7.7 Million |
| Debt repayment | - | -1 Million | -1.65 Million | -3.3 Million | -1.65 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -10 Thousand | 4005.00 | - | -5.00 |
| Common Stock Issuance | - | 8.08 Million | 23.05 Million | 1000.00 | -19 Thousand | 7.71 Million |
| Other Financing Activities | - | -1 Million | 24.54 Million | 29.49 Million | 1.65 Million | -4995.00 |
| Accounts receivables | - | - | - | 112 Thousand | 37 Thousand | -149 Thousand |
| Accounts payables | 5.53 Million | -957 Thousand | 7.06 Million | 2.69 Million | -1.44 Million | 1.16 Million |
| Inventory | - | - | - | -112 Thousand | -37 Thousand | 149 Thousand |
| Other working capital | 1.34 Million | - | -7.06 Million | 514 Thousand | 2.74 Million | -1.46 Million |
| Cash at beginning of period | 262 Thousand | 2.57 Million | 1.28 Million | 907 Thousand | 7.2 Million | 5.23 Million |
| Cash at end of period | 59 Thousand | 262 Thousand | 2.57 Million | 2.57 Million | 907 Thousand | 7.2 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 3000.00 | -6000.00 | - | 2000.00 | -2000.00 | 3000.00 |
| Net cash flow / Change in cash | -203 Thousand | -2.31 Million | 1.29 Million | 1.67 Million | -6.29 Million | 1.97 Million |
| Free Cash Flow | -981 Thousand | -9.39 Million | -25.24 Million | -3.08 Million | -6.67 Million | -5.74 Million |
1293
QINTER
VIMGF
LKHLY
RIV
CVCB3